ARMProgram.com Trend Top Navigation






Proteus mirabilis (SOUTHCENTRAL Data)
  2004 2005 2006 2007 2008 2009 2010
amoxicillin/clavulanate 100%
n=31
      
ampicillin 75.7%
n=280
97.5%
n=40
     
ampicillin/sulbactam 78.6%
n=280
95%
n=40
     
cefazolin 82.9%
n=280
92.5%
n=40
     
cefotetan 100%
n=55
      
cefuroxime 92.7%
n=150
      
cefotaxime 100%
n=86
      
ceftazidime 99.5%
n=193
100%
n=40
     
ceftriaxone 99.1%
n=225
100%
n=40
     
cefepime 100%
n=280
97.5%
n=40
     
ciprofloxacin 64.6%
n=280
47.5%
n=40
     
levofloxacin 71.1%
n=280
47.5%
n=40
     
gatifloxacin 72.2%
n=54
      
TMP/SMX 74.6%
n=138
65%
n=40
     
gentamicin 86.4%
n=280
92.5%
n=40
     
tobramycin 87.1%
n=280
90%
n=40
     
amikacin 100%
n=31
      
aztreonam 93.5%
n=31
      
imipenem 93.9%
n=280
100%
n=40
     
piperacillin 70.5%
n=173
      
pip/taz 98.2%
n=278
100%
n=40
     
ticarcillin/clavulanate 98.8%
n=86
      
Totals85.9%
n=4051
86.5%
n=520
         

This data is accurate as of: 11/22/2016 11:55:24 AM

Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: amoxicillin/clavulanate, cefotetan, cefotaxime, gatifloxacin, amikacin, aztreonam, ticarcillin/clavulanate, ampicillin, ampicillin/sulbactam, cefazolin, ceftazidime, ceftriaxone, cefepime, ciprofloxacin, levofloxacin, TMP/SMX, gentamicin, tobramycin, imipenem, pip/taz.



Site Menu: Home Page | About ARM | Trends | Contact Us

University of Florida ARMProgram.com is a project run by the University of Florida.
Copyright 2011. All Rights Reserved.
Site by JMarc Technologies, LLC